Dear readers,
AstraZeneca’s AZD1222 vaccine has driven the UK’s response to the Covid-19 pandemic, with over 54 million doses delivered to the public.
In this case study, Maggie Spong, AstraZeneca’s vice president talent acquisition, explains how she and her colleagues met specialised staffing challenges – and how they have used this extraordinary situation as an opportunity to promote company diversity.
Have a view on the matter? Join our exclusive LinkedIn group and discuss with fellow leaders.